Suppliers / Pt. Harsen Laboratories

Pt. Harsen Laboratories

Indonesia 213 employees Updated 9 July 2026

Pt. Harsen Laboratories is a finished-dose manufacturer based in Indonesia. It appears in 146 regulatory filings across 5 regulators, without an active US DMF or CEP on file. Its filings concentrate with BPOM (ID), ARCSA (EC) and NAFDAC (NG). Its GMP standing is certified by BPOM (ID) and NAFDAC (NG). Customs aggregates show $1.4M of exports covering 9 molecules to 3 destinations in 2025.

0
active US DMFs
0
valid CEPs
4
registered plants
146
filings across 5 regulators

Registered plants

Site FDA FEI
-, Indonesia Not on file
-, Indonesia Not on file
KODYA JAKARTA TIMUR, Indonesia Not on file
JAKARTA, Indonesia Not on file

Filings and GMP by regulator

Regulator Filings GMP certificates
BPOM (ID) 135 12
ARCSA (EC) 7 None
NAFDAC (NG) 2 1
MINSA (CR) 1 None
DIGEMAPS (DO) 1 None

Scale

Year Revenue Exports Destinations
2025 Not reported $1.4M 3
2024 Not reported $1.8M 2

Export figures are customs aggregates. We do not publish the identity of any buyer.

Comparing suppliers?

Choose your molecules and target markets. Pt. Harsen Laboratories comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates
Customs aggregates
Export values, molecule and destination counts